# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0000875045-19-000019
Filing Date
2019-04-29
Accepted
2019-04-29 07:33:27
Documents
4
Period of Report
2019-04-29
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | a8-kdirapril292019.htm | 8-K | 19995
2 | EXHIBIT 99.1 | finalbiogenboardnominees.htm | EX-99.1 | 26244
3 |  | biogenlogostandarda18.jpg | GRAPHIC | 756402
4 |  | finalbiogenboardnomin_image1.gif | GRAPHIC | 5810
| Complete submission text file | 0000875045-19-000019.txt |  | 1076813

Mailing Address 225 BINNEY STREET CAMBRIDGE MA 02142
Business Address 225 BINNEY STREET CAMBRIDGE MA 02142 7814642000
BIOGEN INC. (Filer) CIK: 0000875045 (see all company filings)

EIN.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19311 | Film No.: 19773715
SIC: 2836 Biological Products, (No Diagnostic Substances)